103 related articles for article (PubMed ID: 22475558)
1. Discovery of an orally-bioavailable CC Chemokine Receptor 2 antagonist derived from an acyclic diaminoalcohol backbone.
Carter PH; Brown GD; King SR; Voss ME; Tebben AJ; Cherney RJ; Mandlekar S; Lo YC; Yang G; Miller PB; Scherle PA; Zhao Q; Decicco CP
Bioorg Med Chem Lett; 2012 May; 22(9):3311-6. PubMed ID: 22475558
[TBL] [Abstract][Full Text] [Related]
2. Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2.
Xue CB; Wang A; Meloni D; Zhang K; Kong L; Feng H; Glenn J; Huang T; Zhang Y; Cao G; Anand R; Zheng C; Xia M; Han Q; Robinson DJ; Storace L; Shao L; Li M; Brodmerkel CM; Covington M; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B
Bioorg Med Chem Lett; 2010 Dec; 20(24):7473-8. PubMed ID: 21036044
[TBL] [Abstract][Full Text] [Related]
3. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent, orally bioavailable small-molecule inhibitors of the human CCR2 receptor.
Doyon J; Coesemans E; Boeckx S; Buntinx M; Hermans B; Van Wauwe JP; Gilissen RA; De Groot AH; Corens D; Van Lommen G
ChemMedChem; 2008 Apr; 3(4):660-9. PubMed ID: 18188859
[TBL] [Abstract][Full Text] [Related]
5. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
Yang MG; Xiao Z; Shi Q; Cherney RJ; Tebben AJ; De Lucca GV; Santella JB; Mo R; Cvijic ME; Zhao Q; Barrish JC; Carter PH
Bioorg Med Chem Lett; 2012 Feb; 22(3):1384-7. PubMed ID: 22225639
[TBL] [Abstract][Full Text] [Related]
7. Novel, orally bioavailable gamma-aminoamide CC chemokine receptor 2 (CCR2) antagonists.
Pasternak A; Marino D; Vicario PP; Ayala JM; Cascierri MA; Parsons W; Mills SG; Maccoss M; Yang L
J Med Chem; 2006 Aug; 49(16):4801-4. PubMed ID: 16884289
[TBL] [Abstract][Full Text] [Related]
8. The discovery of novel cyclohexylamide CCR2 antagonists.
Lanter JC; Markotan TP; Zhang X; Subasinghe N; Kang FA; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Molloy CJ; Sui Z
Bioorg Med Chem Lett; 2011 Dec; 21(24):7496-501. PubMed ID: 22061641
[TBL] [Abstract][Full Text] [Related]
9. Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonist.
Zheng C; Cao G; Xia M; Feng H; Glenn J; Anand R; Zhang K; Huang T; Wang A; Kong L; Li M; Galya L; Hughes RO; Devraj R; Morton PA; Rogier DJ; Covington M; Baribaud F; Shin N; Scherle P; Diamond S; Yeleswaram S; Vaddi K; Newton R; Hollis G; Friedman S; Metcalf B; Xue CB
Bioorg Med Chem Lett; 2011 Mar; 21(5):1442-6. PubMed ID: 21295478
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
[TBL] [Abstract][Full Text] [Related]
12. Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity.
Brown GD; Shi Q; Delucca GV; Batt DG; Galella MA; Cvijic ME; Liu RQ; Qiu F; Zhao Q; Barrish JC; Carter PH
Bioorg Med Chem Lett; 2016 Jan; 26(2):662-666. PubMed ID: 26631321
[TBL] [Abstract][Full Text] [Related]
13. gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.
Cherney RJ; Mo R; Meyer DT; Voss ME; Yang MG; Santella JB; Duncia JV; Lo YC; Yang G; Miller PB; Scherle PA; Zhao Q; Mandlekar S; Cvijic ME; Barrish JC; Decicco CP; Carter PH
Bioorg Med Chem Lett; 2010 Apr; 20(8):2425-30. PubMed ID: 20346664
[TBL] [Abstract][Full Text] [Related]
14. Substituted dipiperidine alcohols as potent CCR2 antagonists.
Xia M; Hou C; Demong D; Pollack S; Pan M; Brackley J; Singer M; Matheis M; Cavender D; Wachter M
Bioorg Med Chem Lett; 2008 Jun; 18(12):3562-4. PubMed ID: 18487045
[TBL] [Abstract][Full Text] [Related]
15. Spiroindenes and spiroindanes as antagonists of CC chemokine receptor 2: WO 2009023754.
Carter PH
Expert Opin Ther Pat; 2010 Feb; 20(2):283-9. PubMed ID: 20100008
[TBL] [Abstract][Full Text] [Related]
16. Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012.
Carter PH
Expert Opin Ther Pat; 2013 May; 23(5):549-68. PubMed ID: 23428142
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Potent and Orally Bioavailable Dual Antagonist of CC Chemokine Receptors 2 and 5.
Carter PH; Brown GD; Cherney RJ; Batt DG; Chen J; Clark CM; Cvijic ME; Duncia JV; Ko SS; Mandlekar S; Mo R; Nelson DJ; Pang J; Rose AV; Santella JB; Tebben AJ; Traeger SC; Xu S; Zhao Q; Barrish JC
ACS Med Chem Lett; 2015 Apr; 6(4):439-44. PubMed ID: 25893046
[TBL] [Abstract][Full Text] [Related]
18. The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.
Cumming JG; Bower JF; Waterson D; Faull A; Poyser PJ; Turner P; McDermott B; Campbell AD; Hudson J; James M; Winter J; Wood C
Bioorg Med Chem Lett; 2012 Jun; 22(12):3895-9. PubMed ID: 22608963
[TBL] [Abstract][Full Text] [Related]
19. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists.
Cherney RJ; Mo R; Meyer DT; Nelson DJ; Lo YC; Yang G; Scherle PA; Mandlekar S; Wasserman ZR; Jezak H; Solomon KA; Tebben AJ; Carter PH; Decicco CP
J Med Chem; 2008 Feb; 51(4):721-4. PubMed ID: 18232650
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
